Seelos Therapeutics

$3.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+5.05%) Today
+$0.04 (+1.28%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SEEL and other stocks, options, and ETFs commission-free!

About SEEL

Seelos Therapeutics, Inc. Common Stock, also called Seelos Therapeutics, is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio includes late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY. The listed name for SEEL is Seelos Therapeutics, Inc. Common Stock.

CEO
Raj Mehra
Employees
6
Headquarters
New York, New York
Founded
—
Market Cap
244.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.09M
High Today
$3.23
Low Today
$2.89
Open Price
$3.16
Volume
1.82M
52 Week High
$4.44
52 Week Low
$0.4195

SEEL Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

INN-D
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure